The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

FLORENCE, Italy, October 12, 2018 /PRNewswire/ --

  • Expands on existing commercial and co-development agreement for delafloxacin  
  • Consolidates company's strategic focus......
    . .
    Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Friday, 12 October
Share |